Jane Street’s Cellectis CLLS Stock Holding History

Jane Street’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,700	Closed	-$259K	–	9128
2020 Q4	$259K	Buy	+8,700	New	+$195K	﹤0.01%	6613

Other funds holding CLLS

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Jane Street's CLLS Position: Q2 2023 in Review

Jane Street sold out of Cellectis (CLLS) in Q2 2023, closing a stake of 50,522 shares — an estimated $99.8K sold.

Jane Street first reported a position in CLLS in Q3 2015 and held it in 13 quarters. The position peaked at $4.67M in Q4 2020. 36 funds tracked by Wall St. Rank hold CLLS as of Q2 2023.

Jane Street reported no remaining Cellectis position as of Q2 2023 after selling out during the quarter.
Jane Street sold 50,522 Cellectis shares in Q2 2023, an estimated $99.8K.
Jane Street first reported a position in Cellectis in Q3 2015 and held it in 13 quarters.
Jane Street's Cellectis position peaked at $4.67M in Q4 2020.
36 funds tracked by Wall St. Rank held Cellectis as of Q2 2023.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.